Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990;26(6):467-8.
doi: 10.1007/BF02994102.

Renal effects of S10036 in man

G Deray  1 , D Khayat, C Jacquiaud, J P Bizzari, R Bourbouze, L Musset, M C Jaudon, B Baumelou, C Jacquillat, C Jacobs
Affiliations
Clinical Trial

Renal effects of S10036 in man

G Deray et al. Cancer Chemother Pharmacol. 1990.

Abstract

The renal hemodynamic and tubular effects of S10036 (fotemustine) were evaluated in seven patients with advanced malignancy. Initial evaluation carried out prior to treatment and repeated 1 day after the first fotemustine infusion and 7 days after the second included clinical, haematological parameters, liver-function tests, and determination of the glomerular filtration rate, renal blood flow and enzymuria. The glomerular filtration rate was 108 +/- 3.7 ml/min before treatment and remained stable after the first (117 +/- 5 ml/min) and second (124 +/- 6 ml/min) fotemustine infusions. Renal blood flow and urinary beta 2-microglobulin and N'-acetylglucosaminidase excretion were also not modified by fotemustine administration. We conclude that fotemustine does not acutely alter renal haemodynamics, nor does it have direct tubular toxicity.

PubMed Disclaimer

References

    1. N Engl J Med. 1979 May 24;300(21):1200-3 - PubMed
    1. Am J Med. 1981 Dec;71(6):967-72 - PubMed
    1. Clin Chim Acta. 1981 May 5;112(2):149-57 - PubMed
    1. N Engl J Med. 1984 Sep 13;311(11):699-705 - PubMed
    1. Transplantation. 1973 Jan;15(1):176-9 - PubMed

MeSH terms

LinkOut - more resources